2. Search Result
Search Result
Results for "

Lactobacillus

" in MedChemExpress (MCE) Product Catalog:

68

Inhibitors & Agonists

1

Fluorescent Dyes

5

Biochemical Assay Reagents

11

Peptides

26

Natural
Products

4

Isotope-Labeled Compounds

1

GMP Molecules

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N8461
    Reuterin
    3 Publications Verification

    3-Hydroxypropionaldehyde; 3-Hydroxypropanal

    		 Bacterial Infection
    Reuterin is a broad-spectrum antimicrobial agent active against Gram positive and Gram negative bacteria, as well as yeasts, moulds and protozoa. Reuterin is produced by specific strains of Lactobacillus reuteri during anaerobic metabolism of glycerol. Reuterin also demonstrates potent antimicrobial activity against a broad panel of human and poultry meat campylobacter spp. Isolates .
    Reuterin
  • HY-41324
    7-keto-Deoxycholic acid
    1 Publications Verification

    		 Drug Metabolite Others
    7-keto-Deoxycholic acid is a metabolite of bile acids in Clostridium absonum. 7-keto-Deoxycholic acid is also converted from Lactobacillus and Bifidobacterium with specific condition .
    7-keto-Deoxycholic acid
  • HY-113016
    Elaidic acid
    4 Publications Verification

    		 Apoptosis Wnt ERK Bacterial Interleukin Related Infection Metabolic Disease Cancer
    Elaidic acid is an orally active trans fatty acid. Elaidic acid enhances the stemness of colorectal cancer cells by activating the Wnt/ERK1/2 pathway, thereby promoting cell proliferation, invasion and metastasis, and inhibiting apoptosis. Elaidic acid also inhibits the growth of Lactobacillus and alters the cell surface hydrophobicity of Lactobacillus. Elaidic acid reduces basal 2-deoxyglucose uptake in muscle cells and adipocytes. Elaidic acid can be used in research on colorectal cancer, insulin and other related areas .
    Elaidic acid
  • HY-137335
    6'-Sialyllactose sodium
    1 Publications Verification

    		 Bacterial VEGFR Akt ERK Infection Inflammation/Immunology
    6'-Sialyllactose sodium promotes the growth of beneficial bacteria (such as Bifidobacterium and lactobacillus) and inhibits the proliferation of harmful bacteria. 6'-Sialyllactose sodium exhibits anti-inflammatory and anti-angiogenic activities. 6'-Sialyllactose sodium promotes the muscle health .
    6'-Sialyllactose sodium
  • HY-N7104
    Lactitol

    D-Lactitol

    		 Bacterial Infection Neurological Disease Endocrinology
    Lactitol (D-Lactitol) is a non-absorbable disaccharide and Bacterial regulator. Lactitol reduces the populations of Bacteroides, Clostridium, coliforms and Eubacterium, while increasing the populations of Lactobacillus and Streptococcus. Lactitol can be used in the research of portosystemic encephalopathy and chronic constipation .
    Lactitol
  • HY-W096159
    D-Biotinol

    		Drug Derivative Metabolic Disease Inflammation/Immunology
    D-Biotinol is an orally active alcohol analogue of D-Biotin (HY-B0511). D-Biotinol can replace D-Biotin to restore the biotin deficiency induced by egg whites in rats. D-Biotinol can be used for the study of biotin deficiency disorders .
    D-Biotinol
  • HY-113227
    Oxoadipic acid
    1 Publications Verification

    		 Endogenous Metabolite Inflammation/Immunology
    Oxoadipic acid is a key intermediate metabolite in the lysine degradation pathway. The level of Oxoadipic acid is significantly negatively correlated with the abundance of Staphylococcus. That is, the higher the abundance of Staphylococcus-a potential pathogenic bacterium that usually increases in ulcerative colitis-the lower the level of Oxoadipic acid. Oxoadipic acid can be used in the research of ulcerative colitis .
    Oxoadipic acid
  • HY-B1389
    Lactitol monohydrate

    D-Lactitol monohydrate

    		 Bacterial Infection Neurological Disease Endocrinology
    Lactitol monohydrate (D-Lactitol monohydrate) is a non-absorbable disaccharide and Bacterial regulator. Lactitol monohydrate reduces the populations of Bacteroides, Clostridium, coliforms and Eubacterium, while increasing the populations of Lactobacillus and Streptococcus. Lactitol monohydrate can be used in the research of portosystemic encephalopathy and chronic constipation .
    Lactitol monohydrate
  • HY-N10521
    6'-Sialyllactose
    1 Publications Verification

    		 Bacterial VEGFR Akt ERK Infection Inflammation/Immunology
    6'-Sialyllactose promotes the growth of beneficial bacteria (such as Bifidobacterium and lactobacillus) and inhibits the proliferation of harmful bacteria. 6'-Sialyllactose exhibits anti-inflammatory and anti-angiogenic activities. 6'-Sialyllactose promotes the muscle health .
    6'-Sialyllactose
  • HY-W012836
    4-Ethylphenol
    1 Publications Verification

    		 Environmental Pollutants Endogenous Metabolite Neurological Disease
    4-Ethylphenol is a volatile phenolic compound associated with off-odour in wine. 4-Ethylphenol is a phenolic compound that can be synthesized by intestinal flora. 4-Ethylphenol will be converted to 4-ethylphenyl sulfate (HY-W674241) by Lactobacillus plantarum .
    4-Ethylphenol
  • HY-126389B
    Chitin, from shrimp shells (chitinase substrate)

    		Endogenous Metabolite NF-κB Fungal Infection Inflammation/Immunology
    Chitin, from shrimp shells (chitinase substrate) serves as a substrate for chitinase. Chitin, from shrimp shells (chitinase substrate) is a long-chain polymer of N-acetylglucosamine with β-(1-4) linkages. Chitin, from shrimp shells (chitinase substrate) is found in the exoskeleton of crabs. Chitin, from shrimp shells (chitinase substrate) inhibits the activation of NF-κB p65, alters the translocation of NF-κB p65 to the nucleus, and interacts with the cell wall of Candida species. Chitin, from shrimp shells (chitinase substrate) exerts antifungal and anti-inflammatory effects. Chitin, from shrimp shells (chitinase substrate) can be used in the research of gastric ulcer and candidiasis .
    Chitin, from shrimp shells (chitinase substrate)
  • HY-107863
    Fructooligosaccharides

    Oligolevulose

    		 Biochemical Assay Reagents Bacterial Infection Metabolic Disease
    Fructooligosaccharides (Oligolevulose) are a class of orally active dietary fibers and prebiotics. Fructooligosaccharides exist in foods such as breast milk, wheat, honey, onions, garlic and bananas. Fructooligosaccharides resist hydrolysis by the body's digestive enzymes and stimulate the growth of beneficial intestinal bacteria through colonic fermentation. Fructooligosaccharides significantly prevent bone loss in the femur and lumbar spine .
    Fructooligosaccharides
  • HY-113268
    Biotin sulfone
    2 Publications Verification

    		 Endogenous Metabolite Metabolic Disease
    Biotin sulfone, a structural analog and metabolite of Biotin (HY-B0511), exerts competitive inhibition against Biotin in Lactobacillus arabinosus 17-5 .
    Biotin sulfone
  • HY-P3752
    Gly-Ala-Tyr

    H-Gly-Ala-Tyr-OH

    		 Biochemical Assay Reagents Bacterial Others
    Gly-Ala-Tyr (H-Gly-Ala-Tyr-OH) is a tripeptide substrate composed of L-glycine, alanine, and L-tyrosine joined in sequence by peptide linkages. Gly-Ala-Tyr can be hydrolyzed at both extracellular and intracellular levels by Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and Bifidobacterium spp. Ala-Gly-Tyr is functionally related to L-alanine, glycine and L-tyrosine. .
    Gly-Ala-Tyr
  • HY-P11146
    SppIP

    Sakacin P inducer peptide

    		 Bacterial Infection
    SppIP (Sakacin P inducer peptide) is a peptide consisting of 19 amino acids . SppIP is an essential inducer for sakacin P production . SppIP can induce the expression of PRRSV GP5 and SARS-CoV-2 spike protein in recombinant Lactobacillus plantarum. SppIP can activate the transcription of the sakacin P promoter to drive the expression of downstream heterologous capsid proteins, increasing the proportion of PCV2d capsid proteins displayed on the cell surface of Lactobacillus plantarum. SppIP can be used in studies related to sakacin P induction .
    SppIP
  • HY-30216
    (R)-Leucic acid

    D-α-Hydroxyisocaproic acid

    		 Amino Acid Derivatives Endogenous Metabolite Metabolic Disease
    (R)-Leucic acid (D-α-Hydroxyisocaproic acid) is an orally active D-isomer of the α-hydroxy analogue of Leucine (HY-N0486). (R)-Leucic acid is a metabolite of Lactobacillus and can promote intestinal fatty acid absorption by upregulating CD36 expression. (R)-Leucic acid can be used to study microbe-host interactions and the regulation of lipid metabolism by probiotics .
    (R)-Leucic acid
  • HY-P2877
    Tannase

    		Endogenous Metabolite Others
    Tannase is a tannin acyl hydrolase. Tannase catalyzes the hydrolysis of ester bonds in gallotannins, complex tannins and gallic acid esters to release gallic acid. Tannase plays a role in industrial production, including the manufacture of instant tea, beer, fruit juice, some wines, and the production of gallic acid .
    Tannase
  • HY-W403933
    12-Ketochenodeoxycholic acid

    		Endogenous Metabolite Metabolic Disease
    12-Ketochenodeoxycholic acid is an anomalous bile acid and Chenodeoxycholic acid (HY-76847) precursor. 12-Ketochenodeoxycholic acid can be used for the research of hepatobiliary diseases .
    12-Ketochenodeoxycholic acid
  • HY-P5589
    Plantaricin A

    PlnA

    		 Bacterial Reactive Oxygen Species (ROS) Infection Inflammation/Immunology
    Plantaricin A is an antimicrobial peptide that can be derived from Lactobacillus plantarum. Plantaricin A has a synergistic effect with Ciprofloxacin. Plantaricin A shows anti-microbial activity. Plantaricin A increases the membrane potential of S. aureus and the level of intracellular ROS. Plantaricin A inhibits the function of the efflux pump by binding it and altering the structure of MepA, NorA, and LmrS. Plantaricin A significantly relieves inflammation, and promotes wound healing. Plantaricin A permeabilizes cancerous rat pituitary cells [1][2].
    Plantaricin A
  • HY-W013755
    Dioctyl phthalate
    2 Publications Verification

    DNOP; Di-n-octyl phthalate; Phthalic acid dioctyl ester

    		 Biochemical Assay Reagents Aminotransferases (Transaminases) Phosphatase Bacterial Inflammation/Immunology
    Dioctyl phthalate (DNOP) is a plasticizer. Dioctyl phthalate increases the activities of alanine aminotransferase (ALT) and alkaline phosphatase (ALP) in the liver, as well as the levels of creatinine and urea in the kidney. Exposure to Dioctyl phthalate disrupts the homeostasis of the intestinal microbial community, increases the abundance of pathogenic bacteria, and reduces the abundance of beneficial bacteria such as Lactobacillus. Dioctyl phthalate induces significant and dose-dependent inflammatory responses in the liver, spleen and kidney of mice .
    Dioctyl phthalate
  • HY-139410
    Sodium caseinates

    		c-Fms Inflammation/Immunology
    Sodium caseinates is a kind of sodium salts of major milk proteins, which act as protein-based biopolymers and innate immune system activators. Sodium caseinates induce granulopoiesis, activation and differentiation, promote the production of M-CSF, and increase serum levels of G-CSF and GM-CSF. Sodium caseinates inhibit the proliferation and reduce the viability of leukemia macrophage-like cells, thereby significantly improving the survival rate of mice inoculated with leukemia cells. Sodium caseinates can serve as carriers for probiotics in edible films and exhibit anti-Listeria activity. Sodium caseinates effectively protect vitamin A from degradation, enhance its stability, bioaccessibility and bioavailability, and regulate protein digestibility when complexed with vitamin A. Sodium caseinates can be applied to research related to acute monocytic leukemia and vitamin A deficiency .
    Sodium caseinates
  • HY-W049970
    Carvacrol methyl ether

    		Environmental Pollutants Bacterial Infection
    Carvacrol methyl ether is a carvacrol derivative isolated from plant essential oils. Carvacrol methyl ether essentially lost its antibacterial activity, exhibiting only a weak inhibitory effect on Saccharomyces cerevisiae at the highest tested concentration of 3 g/L .
    Carvacrol methyl ether
  • HY-103249
    Reutericyclin

    Reutericycline

    		 Bacterial Infection Metabolic Disease
    Reutericyclin (Reutericycline) is an orally active antibacterial and anti-obesity agent that selectively inhibits Gram-positive bacteria. By selectively dissipating transmembrane potential, Reutericyclin exerts non-lytic bactericidal or bacteriostatic activity against pathogens such as Clostridium difficile and Staphylococcus aureus, and rapidly kills vegetative cells and spores of Clostridium difficile. Reutericyclin possesses favorable properties including resistance to enzymatic hydrolysis, iron-chelating function, and poor absorption by colonic epithelium. Reutericyclin not only eradicates staphylococcal biofilms and inhibits drug-resistant strains, but also counteracts Risperidone (HY-11018)-induced weight gain by inducing changes in gut microbiota composition and restoring energy utilization efficiency. Reutericyclin can be used in research related to Clostridium difficile infection, Risperidone-induced weight gain, and staphylococcal superficial skin infections .
    Reutericyclin
  • HY-E70029
    α-1,6-Fucosidase, lactobacillus casei

    		Others Others
    alpha-1,6-Fucosidase (LpAlfC(E274A)) (EC 3.2.1.51) cleaves branched non-reducing terminal fucose, linked α(1-6) to the core N-acetylglucosamine of N-linked oligosaccharides. alpha-1,6-Fucosidase (LpAlfC(E274A)) is useful for determining core fucosylation .
    α-1,6-Fucosidase, lactobacillus casei
  • HY-120536
    HPi1
    1 Publications Verification

    		 Bacterial Infection
    HPi1 is a potent, selective and orally active antimicrobial against Helicobacter pylori with an IC50 of 0.24 μM and an MIC of 0.08-0.16 μg/mL. HPi1 is inactive against other bacteria, including the gut commensals Lactobacillus casei, Lactobacillus reuteri, and Bifidobacterium longum .
    HPi1
  • HY-P2825
    Tyrosine decarboxylase, Microorganism

    TDC; TyrDC

    		 Endogenous Metabolite Others
    Tyrosine decarboxylase, Microorganism (TDC) is a tyrosine decarboxylase produced by microorganisms. Tyrosine decarboxylase is a PLP-dependent enzyme that catalyzes the decarboxylation of L-tyrosine, L-phenylalanine, and L-dopa to produce tyramine, 2-phenethylamine, and dopamine, respectively. Tyrosine decarboxylase mediates acid stress resistance, maintains intracellular pH homeostasis, and generates proton motive force .
    Tyrosine decarboxylase, Microorganism
  • HY-W001974
    7-Nitroindole

    		DNA/RNA Synthesis Bacterial Others
    7-Nitroindole is a cleavable base analog and Antibacterial agent. 7-Nitroindole inhibits the growth of Lactobacillus arabinosus. 7-Nitroindole is used in studies of light-controlled DNA cleavage and Lactobacillus arabinosus infection .
    7-Nitroindole
  • HY-124003
    Phytomonic acid

    		Endogenous Metabolite Inflammation/Immunology
    Phytomonic acid is a long-chain fatty acid containing a cyclopropane ring produced by Lactobacillus reuteri. Lactobacilli that normally produce Lactobacillic acid also have the ability to resist TNF-α .
    Phytomonic acid
  • HY-N12513
    Cyclo(L-Phe-trans-4-OH-L-Pro)

    		Fungal Infection
    Cyclo(L-Phe-trans-4-OH-L-Pro) is an antifungal peptides .
    Cyclo(L-Phe-trans-4-OH-L-Pro)
  • HY-41324R
    7-keto-Deoxycholic acid (Standard)

    		Drug Metabolite Reference Standards Others
    7-keto-Deoxycholic acid (Standard) is the analytical standard of 7-keto-Deoxycholic acid. This product is intended for research and analytical applications. 7-keto-Deoxycholic acid is a metabolite of bile acids in Clostridium absonum. 7-keto-Deoxycholic acid is also converted from Lactobacillus and Bifidobacterium with specific condition[1][2].
    7-keto-Deoxycholic acid (Standard)
  • HY-W012836S1
    4-Ethylphenol-d10

    		Isotope-Labeled Compounds Endogenous Metabolite Neurological Disease
    4-Ethylphenol-d10 is the deuterium labeled 4-Ethylphenol (HY-W012836). 4-Ethylphenol is a volatile phenolic compound associated with off-odour in wine. 4-Ethylphenol is a phenolic compound that can be synthesized by intestinal flora. 4-Ethylphenol will be converted to 4-ethylphenyl sulfate (HY-W674241) by Lactobacillus plantarum .
    4-Ethylphenol-d10
  • HY-W012836S
    4-Ethylphenol-d5

    		Isotope-Labeled Compounds Endogenous Metabolite Neurological Disease
    4-Ethylphenol-d5 is the deuterium labeled 4-Ethylphenol (HY-W012836). 4-Ethylphenol is a volatile phenolic compound associated with off-odour in wine. 4-Ethylphenol is a phenolic compound that can be synthesized by intestinal flora. 4-Ethylphenol will be converted to 4-ethylphenyl sulfate (HY-W674241) by Lactobacillus plantarum .
    4-Ethylphenol-d5
  • HY-W012836R
    4-Ethylphenol (Standard)

    		Reference Standards Endogenous Metabolite Neurological Disease
    4-Ethylphenol (Standard) is the analytical standard of 4-Ethylphenol (HY-W012836). This product is intended for research and analytical applications. 4-Ethylphenol is a volatile phenolic compound associated with off-odour in wine. 4-Ethylphenol is a phenolic compound that can be synthesized by intestinal flora. 4-Ethylphenol will be converted to 4-ethylphenyl sulfate (HY-W674241) by Lactobacillus plantarum .
    4-Ethylphenol (Standard)
  • HY-P11547
    Plantaricin F

    		Bacterial Infection
    Plantaricin F is an antibacterial peptide. Plantaricin F strongly inhibits several gram-negative bacteria including the foodbome pathogens Salmonella enteritidis and Pseudomonas aeruginosa. Plantaricin F inhibits several Lactobacillus, Pediococcus and Leuconostoc species .
    Plantaricin F
  • HY-135055
    Magnesium lactate

    		Biochemical Assay Reagents Others
    Magnesium lactate is a magnesium additive, which is used in food, beverages and pharmaceutical industries .
    Magnesium lactate
  • HY-P11134
    Leucocin A

    LeuA

    		 Bacterial Infection
    Leucocin A (LeuA), a 37-amino acid peptide, is a class II bacteriocin without Lanthionine (HY-135113). Leucocin A has potent anti-bacterial activity against gram-positive bacteria, such as Leuconostoc paramesenteroides and Lactobacillus sake with MICs of 69 and 39 nM, respectively. Leucocin A can be used for infectious diseases research .
    Leucocin A
  • HY-171837
    c9,t11,c15-CLNA

    		Caspase Cancer
    c9,t11,c15-CLNA is a conjugated linolenic acid (CLNA) isomer produced by Lactobacillus plantarum ZS2058. c9,t11,c15-CLNA has significant anti-proliferation activity against colon cancer cells (IC50: 18.26 μM). c9,t11,c15-CLNA induces pyroptosis by activating the canonical pyroptosis pathway mediated by caspase-1. c9,t11,c15-CLNA can be used in the study of colon cancer .
    c9,t11,c15-CLNA
  • HY-W983371
    10(R)-Hydroxystearic acid

    (R)-10-Hydroxyoctadecanoic acid; (R)-10-HSA

    		 Drug Derivative Bacterial Infection
    10(R)-Hydroxystearic acid is a derivative of Oleic acid (HY-N1446). 10(R)-Hydroxystearic acid can be biocatalytically produced by Lactobacillus rhamnosus ATCC 53103 .
    10(R)-Hydroxystearic acid
  • HY-126878
    11-Oxahomoaminopterin

    		Antifolate Infection Cancer
    11-Oxahomoaminopterin shows antifolate activity and inhibits Lactobacillus casei DHFFZ with antimicrobial and antitumor activities .
    11-Oxahomoaminopterin
  • HY-W142014
    N,O-Didansyl-L-tyrosine cyclohexylammonium

    		Thymidylate Synthase Cancer
    N,O-Didansyl-L-tyrosine cyclohexylammonium is a potent selective thymidylate synthase (TS) inhibitor, acts on TS of Escherichia coli, Lactobacillus casei and human with the IC50 values of 5.0, 3.4 and 119 μM, respectively .
    N,O-Didansyl-L-tyrosine cyclohexylammonium
  • HY-122518
    8-Deazafolic acid

    		Bacterial Inflammation/Immunology
    8-Deazafolic acid is an antimicrobial drug for the folate-dependent bacteria, Streptococcus faecium (ATCC 8043) and Lactobacillus casei (ATCC 74691). 8-Deazafolic acid has activity against lymphoid leukemia L1210 in mice .
    8-Deazafolic acid
  • HY-131518
    Lycomarasmin

    		Bacterial Infection
    Lycomarasmin has the inhibitory effect of lactobacillus casei, and it is a plant toxin .
    Lycomarasmin
  • HY-P11138
    Lactocin 705α

    Lac705α

    		 Biochemical Assay Reagents Bacterial Infection
    Lactocin 705α (Lac705α) is a peptide component of Lactocin 705. Lactocin 705α can interact with zwitterionic DPPC bilayers. Lactocin 705α can induce the dehydration of the bilayer interfacial region. Lactocin 705α can be used in the research of bacterial infections .
    Lactocin 705α
  • HY-P11187
    Bactofencin A

    		Bacterial Infection
    Bactofencin A is a novel class IId bacteriocin. Bactofencin A can be produced by the intestinal isolate Lactobacillus salivarius DPC6502. Bactofencin A displays activity against S. aureus and Listeria spp .
    Bactofencin A
  • HY-P10134
    Salivaricin B

    		Bacterial Infection
    Salivaricin B is a broad-spectrum bacteriocin produced by Lactobacillus salivarius M7, capable of inhibiting the growth of Listeria monocytogenes, Bacillus cereus, Brochothrix thermosphacta, Enterococcus faecalis, and various lactobacilli .
    Salivaricin B
  • HY-121785
    10-Thiofolic acid

    		Bacterial Infection Cancer
    10-Thiofolic acid is a potent antibacterial and antitumor agent. 10-Thiofolic acid inhibits the growth of Streptococcus faecium (ATCC 8043) and Lactobacillus casei (ATCC 7469). 10-Thiofolic acid has the potential for the research of leukemia .
    10-Thiofolic acid
  • HY-N12513R
    Cyclo(L-Phe-trans-4-OH-L-Pro) (Standard)

    		Reference Standards Fungal Infection
    5α-Cholestan-3β-ol (Standard) is the analytical standard of 5α-Cholestan-3β-ol. This product is intended for research and analytical applications. 5α-Cholestan-3β-ol is a derivitized steroid compound.
    Cyclo(L-Phe-trans-4-OH-L-Pro) (Standard)
  • HY-N12016
    Fulvotomentoside B

    		Others Metabolic Disease
    Fulvotomentoside B is a saponin isolated from Lactobacillus flavus. Fulvotomentoside compounds can significantly reduce serum glutamate pyruvate transaminase (SGPT) and triacylglycerol (GT) levels in mice poisoned by CCl4, d-galactosamine (d-gal) and acetaminophen, and significantly alleviate liver pathology. damage .
    Fulvotomentoside B
  • HY-113268R
    Biotin sulfone (Standard)

    		Reference Standards Endogenous Metabolite Metabolic Disease
    Biotin sulfone (Standard) is the analytical standard of Biotin sulfone (HY-113268). This product is intended for research and analytical applications. Biotin sulfone, a structural analog and metabolite of Biotin (HY-B0511), exerts competitive inhibition against Biotin in Lactobacillus arabinosus 17-5 .
    Biotin sulfone (Standard)
  • HY-N7104R
    Lactitol (Standard)

    D-Lactitol (Standard)

    		 Reference Standards Bacterial Infection Neurological Disease Metabolic Disease Endocrinology
    Lactitol (Standard) is the analytical standard of Lactitol (HY-N7104). This product is intended for research and analytical applications. Lactitol (D-Lactitol) is a non-absorbable disaccharide and Bacterial regulator. Lactitol reduces the populations of Bacteroides, Clostridium, coliforms and Eubacterium, while increasing the populations of Lactobacillus and Streptococcus. Lactitol can be used in the research of portosystemic encephalopathy and chronic constipation .
    Lactitol (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: